Reformulary Group Inc.

Subscription-based product for Canadian drug plans, giving better health outcomes at a substantially lower cost, and data analytics service for pharma

  • Stage $1M in TTM Revenue
  • Industry Healthcare Services
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded March 2011
  • Employees 11
  • Incorporation Type Other
  • Website reformulary.com

Company Summary

We offer our proprietary list of drugs to employers on a subscription basis; it reduces drug spend & provides better health outcomes. DrugFinder™ digital tool helps Canadians make smart drug choices.

Our data analytics uses our prescription drug claims data for 11 mm Canadians or 1.2B records. We sell subscriptions to pharma for our BI product that transforms the data into valuable insights & a predictive modelling tool to insurers.

Team

  • Helen Stevenson
    CEO and Founder

    Private and public experience; public sector reforming and managing second largest drug plan in North America. Her experience drives the business; her contacts are pivotal in sales and pharma negotiations

  • Allan Levine
    VP, Operations

    His experience in scaling & operating will move the business to a profitable model

  • Heather Nicol
    CFO

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free